Moreover, in some clinical studies IL‐33 concentrations showed different behavior in health and disease,38, 39 suggesting a downregulation in some chronic inflammatory diseases such as type 2 diabetes and obesity, limiting inflammatory damage. Here, IL33 is linked to obesity due to melanocortin 4 receptor deficiency.